What your Mounjaro consultation actually involves

You've found Mounjaro online and want to know if you can actually get it

That is probably the most common starting point. Someone hears about tirzepatide, reads the trial results, and then hits the same wall: it is a prescription-only medicine, so Google searches and pharmacy websites only go so far. The consultation is the gateway, and understanding what it involves makes the whole thing far less daunting.

At its core, a Mounjaro consultation is a structured clinical review. A prescriber looks at your BMI, your weight history, any relevant diagnoses (high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnoea and similar conditions all feature in the licensed eligibility criteria), and the medicines you currently take. They are also looking for reasons tirzepatide might not be safe for you, a history of pancreatitis, certain thyroid conditions, or medicines whose absorption could be affected.

Eligibility for the prescription follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above if at least one weight-related condition is present. Lower thresholds can apply for some ethnic backgrounds under UK guidance. Meeting the BMI threshold does not guarantee a prescription; the prescriber weighs the whole picture. You can read more about the broader landscape of weight-loss treatments and what to expect from the clinical process if you want context before you apply.

The NHS overview of tirzepatide on the NHS medicines pages for tirzepatide is a useful plain-English primer on what the medicine does and how it works before you sit down with a prescriber.

Why the consultation at a regulated online pharmacy includes more than a questionnaire

A questionnaire alone is not a consultation. The distinction matters because the safety of this medicine depends on the quality of the information a prescriber receives, and self-reported data has limits.

At nume, every application is reviewed personally by a GPhC-registered Independent Prescriber. Not a decision tree, not an algorithm. A real clinician reads what you have submitted, that same day. Beyond the health questions, the process includes photo-ID identity verification and live weight confirmation on video, so the BMI a prescriber is working from reflects your actual measurements, not an estimate. For anyone transferring from another provider or requesting a dose increase, clinical evidence is required before the prescriber proceeds.

This level of verification is not bureaucracy for its own sake. It is what separates a prescription issued safely from one that should never have been written. The concern about services offering Mounjaro without a proper consultation is legitimate and worth reading about separately, because the risks are real.

If you are apprehensive about the process itself (the needle, the idea of injections arriving by post) our page for people who feel anxious about starting Mounjaro might be a more useful first read. That is a question our prescribers hear regularly and it is worth addressing directly before the clinical conversation begins.

What is discussed during the consultation, and what the prescriber is looking for

The clinical review is not a test you can fail by being honest. The prescriber is trying to build a complete picture so that if treatment goes ahead, it goes ahead safely.

Expect questions about your weight history, previous attempts at weight management, current diet and activity levels, and any diagnoses that might be relevant. You will be asked about your medicines in detail, some interactions require discussion, and for women taking oral contraceptives, the prescriber will explain that tirzepatide can reduce pill absorption during the first four weeks of treatment and after each dose increase, so an additional method of contraception is advisable during those windows. That conversation happens at consultation, not after the pen arrives.

The prescriber will also go through common side effects in enough detail for you to make an informed decision. The GI effects (nausea, loose stools, indigestion, reduced appetite) are the most frequently reported, particularly in the early weeks, and if you are wondering whether changes to your heart rate are also possible, our page on Mounjaro palpitations explains what the evidence says about that specific concern. For a balanced view of what the medicine involves clinically, the pros and cons of Mounjaro page covers the evidence honestly, including the things worth knowing before you commit. If you have specific concerns about one type of side effect, the drawbacks of Mounjaro discussed in detail may answer them.

Once the prescriber is satisfied that treatment is appropriate, the prescription is issued. At nume, orders placed before 12pm are dispatched the same working day. What arrives is a plain, unbranded box via DPD with a tracking link, inside is the KwikPen, the Patient Information Leaflet and everything you need to start. The pen itself is pre-filled and ready to use; the leaflet walks you through the first injection step by step.

Repeat consultations: the clinical review does not stop at the first prescription

A Mounjaro prescription is not a standing order. Before each repeat supply, a prescriber reviews your case again, checking that the current dose is still appropriate, that no new contraindications have emerged, and that the treatment is producing the expected clinical benefit. There are no automatic renewals at nume. Every order goes through the same review.

This matters because tirzepatide is a titrated medicine. Treatment typically starts at 2.5mg (a dose set for tolerability, not yet at therapeutic level) and the prescriber moves you through the schedule as your body adjusts. Each dose step is a clinical decision, and the repeat consultation is where that decision is made. For a detailed look at what tirzepatide is and how it works physiologically, the tirzepatide overview covers the dual GIP and GLP-1 mechanism clearly.

NICE's appraisal of tirzepatide, published as NICE technology appraisal TA1026, also notes that continuing treatment is reviewed if less than five percent weight loss has been achieved after six months at the highest tolerated dose. A good prescriber will have that conversation openly rather than leaving you to wonder.

Aftercare access matters too. Questions come up between doses, about a missed injection, an unexpected side effect, a change in another medicine. The contact page lists how to reach the clinical team, and nume offers priority aftercare seven days a week. You can also review the frequently asked questions for answers to the queries that come up most often after treatment begins.